GLP-1 use tied to obesity decline, but doctors warn of alarming misuse

GLP-1 drugs are linked to a decline in obesity. The drugs are associated with weight loss. Research suggests that Calocurb, a GLP-1 option, may help preserve muscle while losing weight. This has led to a shift in gym goals, with strength training replacing weight loss as the top priority. Local patients are finding benefits beyond weight loss. Doctors advise shifting focus from scale numbers to overall health.

However, doctors are warning of alarming misuse. The Newnan Times-Herald notes that GLP-1s are more than just weight-loss drugs. Medscape advises patients to focus on overall health rather than just the number on the scale. NBC 5 Chicago reports that while GLP-1 use is tied to obesity decline, there is a concerning trend of misuse. The trend is complicated by the fact that the drugs are being used for purposes beyond weight loss. India Currents explores the promises and perils of GLP-1 drugs across a lifespan.

UConn Today separates the myths from the science behind GLP-1 medications. KEYE and WJHG provide information on what doctors want patients to know before starting a weight loss shot. The trend is also complicated by the fact that the drugs are being used for purposes beyond weight loss. India Currents explores the promises and perils of GLP-1 drugs across a lifespan. UConn Today separates the myths from the science behind GLP-1 medications. KEYE and WJHG provide information on what doctors want patients to know before starting a weight loss shot.